Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Skye Bioscience, Inc./ 10-K

Annual Report · 10-K

Skye Bioscience, Inc.

SKYENASDAQEQUITYCurrent

Annual Report

Filed Mar 10, 2026Accepted Mar 10, 2026, 4:02 PM EDTCIK 1516551Accession 0001628280-26-016394
View company →Permanent SEC source ↗
Share

Company context

Current securities

SKYENASDAQ · EQUITY · Current

Recent company filings

  1. DEFA14A filingSep 11, 2026
  2. Termination of a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsSep 11, 2026
  3. DEFA14A filingAug 24, 2026
  4. Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesAug 24, 2026
  5. DEFA14A filingAug 20, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗